A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2013
At a glance
- Drugs V 116517 (Primary) ; Naproxen
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 11 Jul 2013 Planned end date changed from 1 Jan 2014 to 1 Aug 2013 as reported by ClinicalTrials.gov.
- 29 May 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 25 Sep 2012 New trial record